Skip to main content
Log in

Gold standard monitoring for HCC cost effective in cirrhosis

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2013 US dollars

Reference

  • Cadier B, et al. Early detection and curative treatment of hepatocellular carcinoma: A cost-effectiveness analysis in France and in the United States. Hepatology : 8 Feb 2017. Available from: URL: http://doi.org/10.1002/hep.28961

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gold standard monitoring for HCC cost effective in cirrhosis. PharmacoEcon Outcomes News 772, 19 (2017). https://doi.org/10.1007/s40274-017-3767-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-3767-4

Navigation